Delivering bioactive molecules as instructive cues to engineered tissues

Expert Opinion on Drug Delivery

Volumn 9, Issue 4, 2012, Pages 473-492

  Gabriel, Doris ^a   Dvir, Tal ^b   Kohane, Daniel S ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Biomaterials; Drug delivery; Growth factors; Tissue engineering

Indexed keywords

ALGINIC ACID; BONE MORPHOGENETIC PROTEIN 2; ELASTIN; ERYTHROPOIETIN; GAMMA INTERFERON; INTERLEUKIN 1BETA; NERVE GROWTH FACTOR; POLYMER; POLYSACCHARIDE; SCATTER FACTOR; SILK FIBROIN; SOMATOMEDIN C; STROMAL CELL DERIVED FACTOR 1; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ASSOCIATION; BIOCOMPATIBILITY; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL GROWTH; CELL VIABILITY; COVALENT BOND; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENDOTHELIUM CELL; ENZYME DEGRADATION; ENZYME MECHANISM; EXTRACELLULAR MATRIX; HUMAN; HYDROGEL; MESENCHYMAL STEM CELL; MICROENVIRONMENT; MOLECULAR LIBRARY; NERVE FIBER GROWTH; PHENOTYPE; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STATIC ELECTRICITY; TISSUE ENGINEERING;

ANTI-INFLAMMATORY AGENTS; CELL SURVIVAL; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MATERIALS TESTING; POLYMERS; STATIC ELECTRICITY; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84858822305     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2012.668521     Document Type: Review

References (206)

1. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-6
2. Kenar H, Kose GT, Toner M, et al. A 3D aligned microfibrous myocardial tissue construct cultured under transient perfusion. Biomaterials 2011;32:5320-9
3. Hou YT, Ijima H, Takei T, Kawakami K. Growth factor/heparinimmobilized collagen gel system enhances viability of transplanted hepatocytes and induces angiogenesis. J Biosci Bioeng 2011;112(3):265-72
4. Delcroix GJ, Schiller PC, Benoit JP, Montero-Menei CN. Adult cell therapy for brain neuronal damages and the role of tissue engineering. Biomaterials 2010;31:2105-20
5. Williams C, Brown XQ, Bartolak-Suki E, et al. The use of micropatterning to control smooth muscle myosin heavy chain expression and limit the response to transforming growth factor beta1 in vascular smooth muscle cells. Biomaterials 2011;32:410-18
6. Madden PW, Lai JN, George KA, et al. Human corneal endothelial cell growth on a silk fibroin membrane. Biomaterials 2011;32:4076-84
7. Dvir T, Kedem A, Ruvinov E, et al. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci USA 2009;106:14990-5
8. Zimmermann WH, Melnychenko I, Wasmeier G, et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006;12:452-8
9. Chen AA, Thomas DK, Ong LL, et al. Humanized mice with ectopic artificial liver tissues. Proc Natl Acad Sci USA 2011;108:11842-7
10. Dallas SL, Rosser JL, Mundy GR, Bonewald LF. Proteolysis of latent transforming growth factor-beta (TGFbeta) -binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. J Biol Chem 2002;277:21352-60
11. Goerges AL, Nugent MA. pH regulates vascular endothelial growth factor binding to fibronectin: A mechanism for control of extracellular matrix storage and release. J Biol Chem 2004;279:2307-15
12. Malafaya PB, Silva GA, Reis RL. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv Drug Deliv Rev 2007;59:207-33
13. Sokolsky-Papkov M, Agashi K, Olaye A, et al. Polymer carriers for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007;59:187-206
14. Purves W, Sadava D, Gordon H. Life: The science of Biology. 7th edition. Freeman, W H and co., 3 A.D: Sunderland, Mass
15. Kim SH, Turnbull J, Guimond S. Extracellular matrix and cell signalling: The dynamic cooperation of integrin, proteoglycan and growth factor receptor. J Endocrinol 2011;209:139-51
16. Dvir T, Timko BP, Kohane DS, Langer R. Nanotechnological strategies for engineering complex tissues. Nat Nanotechnol 2011;6:13-22
17. Brines M, Cerami A. Erythropoietin-mediated tissue protection: Reducing collateral damage from the primary injury response. J Intern Med 2008;264:405-32
18. Walshe TE, Leach LL, D'Amore PA. TGF-beta signaling is required for maintenance of retinal ganglion cell differentiation and survival. Neuroscience 2011;189:123-31
19. Li TS, Cheng K, Lee ST, et al. Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency for myocardial repair. Stem Cells 2010;28:2088-98
20. Tuttle RL, Gill NS, Pugh W, et al. Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med 2001;7:1133-7
21. Romashkova JA, Makarov SS. NF-kappaB is a target of AKT in anti-Apoptotic PDGF signalling. Nature 1999;401:86-90
22. Cheng M, Moretti M, Engelmayr GC, Freed LE. Insulin-like growth factor-I and slow, bi-directional perfusion enhance the formation of tissue-engineered cardiac grafts. Tissue Eng Part A 2009;15:645-53
23. Solchaga LA, Penick KJ, Welter JF. Chondrogenic differentiation of bone marrow-derived mesenchymal stem cells: Tips and tricks. Methods Mol Biol 2011;698:253-78
24. Fan VH, Tamama K, Au A, et al. Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells 2007;25:1241-51
25. Wang F, Li Z, Khan M, et al. Injectable, rapid gelling and highly flexible hydrogel composites as growth factor and cell carriers. Acta Biomater 2010;6:1978-91
26. Scadden DT. The stem-cell niche as an entity of action. Nature 2006;441:1075-9
27. Votteler M, Kluger PJ, Walles H, Schenke-Layland K. Stem cell microenvironments-unveiling the secret of how stem cell fate is defined. Macromol Biosci 2010;10:1302-15
28. Craig CG, Tropepe V, Morshead CM, et al. In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain. J Neurosci 1996;16:2649-58
29. Quito FL, Beh J, Bashayan O, et al. Effects of fibroblast growth factor-4 (k- FGF) on long-term cultures of human bone marrow cells. Blood 1996;87:1282-91
30. Gritti A, Frolichsthal-Schoeller P, Galli R, et al. Epidermal and fibroblast growth factors behave as mitogenic regulators for a single multipotent stem cell-like population from the subventricular region of the adult mouse forebrain. J Neurosci 1999;19:3287-97
31. Bianchi G, Banfi A, Mastrogiacomo M, et al. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 2003;287:98-105
32. Choi SC, Kim SJ, Choi JH, et al. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways. Stem Cells Dev 2008;17:725-36
33. Ling L, Nurcombe V, Cool SM. Wnt signaling controls the fate of mesenchymal stem cells. Gene 2009;433:1-7
34. Baek SH, Kioussi C, Briata P, et al. Regulated subset of G1 growth-control genes in response to derepression by the Wnt pathway. Proc Natl Acad Sci USA 2003;100:3245-50
35. Iglesias-Bartolome R, Gutkind JS. Signaling circuitries controlling stem cell fate: To be or not to be. Curr Opin Cell Biol 2011;23:716-23
36. Muller P, Schier AF. Extracellular movement of signaling molecules. Dev Cell 2011;21:145-58
37. Xu Y, Shi Y, Ding S. A chemical approach to stem-cell biology and regenerative medicine. Nature 2008;453:338-44
38. Hwang NS, Varghese S, Elisseeff J. Controlled differentiation of stem cells. Adv Drug Deliv Rev 2008;60:199-214
39. Ding S, Schultz PG. A role for chemistry in stem cell biology. Nat Biotechnol 2004;22:833-40
40. Dvir T, Benishti N, Shachar M, Cohen S. A novel perfusion bioreactor providing a homogenous milieu for tissue regeneration. Tissue Eng 2006;12:2843-52
41. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 1995;11:73-91
42. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7
43. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669-76
44. Freeman I, Cohen S. The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. Biomaterials 2009;30:2122-31
45. Shen YH, Shoichet MS, Radisic M. Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater 2008;4:477-89
46. Perets A, Baruch Y, Weisbuch F, et al. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res A 2003;65:489-97
47. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-4
48. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-95
49. Jabbarzadeh E, Starnes T, Khan YM, et al. Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: A combined gene therapy-cell transplantation approach. Proc Natl Acad Sci USA 2008;105:11099-104
50. Tilling L, Chowienczyk P, Clapp B. Progenitors in motion: Mechanisms of mobilization of endothelial progenitor cells. Br J Clin Pharmacol 2009;68:484-92
51. Hattori K, Heissig B, Tashiro K, et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 2001;97:3354-60
52. Rota M. SDF-1 axis and myocardial repair. Am J Physiol Heart Circ Physiol 2010;299:H1307-8
53. Kurane A, Simionescu DT, Vyavahare NR. In vivo cellular repopulation of tubular elastin scaffolds mediated by basic fibroblast growth factor. Biomaterials 2007;28:2830-8
54. Zhao J, Zhang N, Prestwich GD, Wen X. Recruitment of endogenous stem cells for tissue repair. Macromol Biosci 2008;8:836-42
55. Schneider BL, Schwenter F, Pralong WF, Aebischer P. Prevention of the initial host immuno-inflammatory response determines the long-term survival of encapsulated myoblasts genetically engineered for erythropoietin delivery. Mol Ther 2003;7:506-14
56. Su J, Hu BH, Lowe WL Jr, et al. Anti-inflammatory peptide-functionalized hydrogels for insulin-secreting cell encapsulation. Biomaterials 2010;31:308-14
57. Canton I, Mckean R, Charnley M, et al. Development of an Ibuprofen-releasing biodegradable PLA/PGA electrospun scaffold for tissue regeneration. Biotechnol Bioeng 2010;105:396-408
58. Ju YM, Yu B, West L, et al. A dexamethasone-loaded PLGA microspheres/collagen scaffold composite for implantable glucose sensors. J Biomed Mater Res A 2010;93:200-10
59. Ding S, Schultz PG. Small molecules and future regenerative medicine. Curr Top Med Chem 2005; 5:383-95
60. Wieghaus KA, Capitosti SM, Anderson CR, et al. Small molecule inducers of angiogenesis for tissue engineering. Tissue Eng 2006;12:1903-13
61. Peters A, Brey DM, Burdick JA. High-throughput and combinatorial technologies for tissue engineering applications. Tissue Eng Part B Rev 2009;15:225-39
62. Hata R, Sunada H, Arai K, et al. Regulation of collagen metabolism and cell growth by epidermal growth factor and ascorbate in cultured human skin fibroblasts. Eur J Biochem 1988;173:261-7
63. Kao J, Huey G, Kao R, Stern R. Ascorbic acid stimulates production of glycosaminoglycans in cultured fibroblasts. Exp Mol Pathol 1990;53(1):10
64. Takahashi T, Lord B, Schulze PC, et al. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 2003; 107:1912-16
65. Wichterle H, Lieberam I, Porter JA, Jessell TM. Directed differentiation of embryonic stem cells into motor neurons. Cell 2002;110:385-97
66. Ding S, Wu TY, Brinker A, et al. Synthetic small molecules that control stem cell fate. Proc Natl Acad Sci USA 2003;100:7632-7
67. Qin J, Li WQ, Zhang L, et al. A stem cell-based tool for small molecule screening in adipogenesis. PLoS One 2010;5:e13014
68. Menendez L, Yatskievych TA, Antin PB, Dalton S. Wnt signaling and a Smad pathway blockade direct the differentiation of human pluripotent stem cells to multipotent neural crest cells. Proc Natl Acad Sci USA 2011;108:19240-5
69. Benoit DS, Schwartz MP, Durney AR, Anseth KS. Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. Nat Mater 2008;7:816-23
70. Alberti K, Davey RE, Onishi K, et al. Functional immobilization of signaling proteins enables control of stem cell fate. Nat Methods 2008;5:645-50
71. Lei Y, Gojgini S, Lam J, Segura T. The spreading, migration and proliferation of mouse mesenchymal stem cells cultured inside hyaluronic acid hydrogels. Biomaterials 2011;32:39-47
72. Kim SE, Song SH, Yun YP, et al. The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function. Biomaterials 2011;32:366-73
73. Sohier J, Vlugt TJ, Cabrol N, et al. Dual release of proteins from porous polymeric scaffolds. J Control Release 2006;111:95-106
74. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001;19:1029-34
75. Boerckel JD, Kolambkar YM, Dupont KM, et al. Effects of protein dose and delivery system on BMP-mediated bone regeneration. Biomaterials 2011;32:5241-51
76. Borselli C, Storrie H, Benesch-Lee F, et al. Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci USA 2010;107:3287-92
77. Simmons CA, Alsberg E, Hsiong S, et al. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 2004;35:562-9
78. Kolambkar YM, Dupont KM, Boerckel JD, et al. An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials 2011;32:65-74
79. Kempen DH, Lu L, Heijink A, et al. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 2009;30:2816-25
80. Chen FM, Zhao YM, Sun HH, et al. Novel glycidyl methacrylated dextran (Dex-GMA)/gelatin hydrogel scaffolds containing microspheres loaded with bone morphogenetic proteins: Formulation and characteristics. J Control Release 2007;118:65-77
81. Fei Z, Hu Y, Wu D, et al. Preparation and property of a novel bone graft composite consisting of rhBMP-2 loaded PLGA microspheres and calcium phosphate cement. J Mater Sci Mater Med 2008;19:1109-16
82. van de Weert M, Jorgensen L, Horn ME, Frokjaer S. Factors of importance for a successful delivery system for proteins. Expert Opin Drug Deliv 2005;2:1029-37
83. Timko BP, Dvir T, Kohane DS. Remotely triggerable drug delivery systems. Adv Mater 2010; 22:4925-43
84. Liu HW, Chen CH, Tsai CL, Hsiue GH. Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation. Bone 2006;39:825-36
85. Fan D, Yin Z, Cheong R, et al. Subcellular-resolution delivery of a cytokine through precisely manipulated nanowires. Nat Nanotechnol 2010;5:545-51
86. Tracy MA, Ward KL, Firouzabadian L, et al. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. Biomaterials 1999;20:1057-62
87. Li SM, Garreau H, Vert M. Structure-property relationships in the case of the degradation of massive poly (a-hydroxy acids) in aqueous media. Part 2. Degradation of lactide-glycolide copolymers:PLA37.5GA25 and PLA75GA25. J Mater Sci Mater Med 1990; 1990:131-9
88. Houchin ML, Topp EM. Chemical degradation of peptides and proteins in PLGA: A review of reactions and mechanisms. J Pharm Sci 2008;97:2395-404
89. Jalil R, Nixon JR. Biodegradable poly (lactic acid) and poly(lactide-co-glycolide) microcapsules: Problems associated with preparative techniques and release properties. J Microencapsul 1990;7:297-325
90. van der Walle CF, Sharma G, Ravi KM. Current approaches to stabilising and analysing proteins during microencapsulation in PLGA. Expert Opin Drug Deliv 2009; 6:177-86
91. Ding AG, Shenderova A, Schwendeman SP. Prediction of microclimate pH in poly(lactic-co-glycolic acid) films. J Am Chem Soc 2006; 128:5384-90
92. King TW, Patrick CW Jr. Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly (ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique. J Biomed Mater Res 2000;51:383-90
93. Kasper FK, Tanahashi K, Fisher JP, Mikos AG. Synthesis of poly (propylene fumarate). Nat Protoc 2009;4:518-25
94. Timmer MD, Ambrose CG, Mikos AG. In vitro degradation of polymeric networks of poly(propylene fumarate) and the crosslinking macromer poly (propylene fumarate)-diacrylate. Biomaterials 2003;24:571-7
95. Sun L, Zhou S, Wang W, et al. Preparation and characterization of protein-loaded polyanhydride microspheres. J Mater Sci Mater Med 2009;20:2035-42
96. Hanes J, Chiba M, Langer R. Degradation of porous poly(anhydrideco- imide) microspheres and implications for controlled macromolecule delivery. Biomaterials 1998;19:163-72
97. Williams JM, Adewunmi A, Schek RM, et al. Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials 2005;26:4817-27
98. Guillaume O, Lavigne JP, Lefranc O, et al. New antibiotic-eluting mesh used for soft tissue reinforcement. Acta Biomater 2011
99. Pektok E, Nottelet B, Tille JC, et al. Degradation and healing characteristics of small-diameter poly(epsiloncaprolactone) vascular grafts in the rat systemic arterial circulation. Circulation 2008;118:2563-70
100. Heller J, Barr J, Ng S, et al. Development of poly(ortho esters) and their application for bovine serum albumin and bupivacaine delivery. J Control Release 2002;78:133-41
101. Nguyen DN, Raghavan SS, Tashima LM, et al. Enhancement of poly (orthoester) microspheres for DNA vaccine delivery by blending with poly(ethylenimine). Biomaterials 2008;29:2783-93
102. Wang C, Ge Q, Ting D, et al. Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines. Nat Mater 2004; 3:190-6
103. Heller J, Barr J. Poly(ortho esters)-from concept to reality. Biomacromolecules 2004;5:1625-32
104. Schwach-Abdellaoui K, Monti A, Barr J, et al. Optimization of a novel bioerodible device based on auto-catalyzed poly(ortho esters) for controlled delivery of tetracycline to periodontal pocket. Biomaterials 2001;22:1659-66
105. Laurencin CT, Koh HJ, Neenan TX, et al. Controlled release using a new bioerodible polyphosphazene matrix system. J Biomed Mater Res 1987;21:1231-46
106. Lakshmi S, Katti DS, Laurencin CT. Biodegradable polyphosphazenes for drug delivery applications. Adv Drug Deliv Rev 2003;55:467-82
107. Ko HF, Sfeir C, Kumta PN. Novel synthesis strategies for natural polymer and composite biomaterials as potential scaffolds for tissue engineering. Philos Transact A Math Phys Eng Sci 2010;368:1981-97
108. Velema J, Kaplan D. Biopolymer-based biomaterials as scaffolds for tissue engineering. Adv Biochem Eng Biotechnol 2006;102:187-238
109. Dang JM, Leong KW. Natural polymers for gene delivery and tissue engineering. Adv Drug Deliv Rev 2006;58:487-99
110. Karr JC, Taddei AR, Picchietti S, et al. A morphological and biochemical analysis comparative study of the collagen products Biopad, Promogram, Puracol, and Colactive. Adv Skin Wound Care 2011;24:208-16
111. Friess W. Collagen-biomaterial for drug delivery. Eur J Pharm Biopharm 1998;45:113-36
112. Ikada Y, Tabata Y. Protein release from gelatin matrices. Adv Drug Deliv Rev 1998;31:287-301
113. Zhu XH, Tabata Y, Wang CH, Tong YW. Delivery of basic fibroblast growth factor from gelatin microsphere scaffold for the growth of human umbilical vein endothelial cells. Tissue Eng Part A 2008; 14:1939-47
114. Numata K, Kaplan DL. Silk-based delivery systems of bioactive molecules. Adv Drug Deliv Rev 2010;62:1497-508
115. Omenetto FG, Kaplan DL. New opportunities for an ancient material. Science 2010;329:528-31
116. Sun L, Wang X, Kaplan DL. A 3D cartilage - Inflammatory cell culture system for the modeling of human osteoarthritis. Biomaterials 2011;32:5581-9
117. Hall H, Baechi T, Hubbell JA. Molecular properties of fibrin-based matrices for promotion of angiogenesis in vitro. Microvasc Res 2001; 62:315-26
118. Daamen WF, Veerkamp JH, van Hest JC, van Kuppevelt TH. Elastin as a biomaterial for tissue engineering. Biomaterials 2007;28:4378-98
119. Chilkoti A, Christensen T, MacKay JA. Stimulus responsive elastin biopolymers: Applications in medicine and biotechnology. Curr Opin Chem Biol 2006;10:652-7
120. Caves JM, Cui W, Wen J, et al. Elastin-like protein matrix reinforced with collagen microfibers for soft tissue repair. Biomaterials 2011;32:5371-9
121. Berger J, Reist M, Chenite A, et al. Pseudo-thermosetting chitosan hydrogels for biomedical application. Int J Pharm 2005;288:197-206
122. Ruel-Gariepy E, Shive M, Bichara A, et al. A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur J Pharm Biopharm 2004;57:53-63
123. Santos E, Zarate J, Orive G, et al. Biomaterials in cell microencapsulation. Adv Exp Med Biol 2010;670:5-21
124. Jourdan G, Dusseault J, Benhamou PY, et al. Co-encapsulation of bioengineered IGF-II-producing cells and pancreatic islets: Effect on beta-cell survival. Gene Ther 2011;18:539-45
125. Ruvinov E, Leor J, Cohen S. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials 2011;32:565-78
126. Balazs EA. Viscosupplementation for treatment of osteoarthritis: From initial discovery to current status and results. Surg Technol Int 2004;12:278-89
127. Joddar B, Kitajima T, Ito Y. The effects of covalently immobilized hyaluronic acid substrates on the adhesion, expansion, and differentiation of embryonic stem cells for in vitro tissue engineering. Biomaterials 2011;32:8404-15
128. Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev 2002;54:3-12
129. Peppas NA, Bures P, Leobandung W, Ichikawa H. Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm 2000;50:27-46
130. Cadee JA, De Groot CJ, Jiskoot W, et al. Release of recombinant human interleukin-2 from dextran-based hydrogels. J Control Release 2002;78:1-13
131. Qiu B, Stefanos S, Ma J, et al. A hydrogel prepared by in situ cross-linking of a thiol-containing poly (ethylene glycol)-based copolymer: A new biomaterial for protein drug delivery. Biomaterials 2003;24:11-18
132. Temenoff JS, Athanasiou KA, LeBaron RG, Mikos AG. Effect of poly (ethylene glycol) molecular weight on tensile and swelling properties of oligo (poly(ethylene glycol) fumarate) hydrogels for cartilage tissue engineering. J Biomed Mater Res 2002;59:429-37
133. Holland TA, Tabata Y, Mikos AG. In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. J Control Release 2003;91:299-313
134. Baldwin AD, Kiick KL. Polysaccharide-modified synthetic polymeric biomaterials. Biopolymers 2010; 94:128-40
135. Freeman I, Kedem A, Cohen S. The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. Biomaterials 2008; 29:3260-8
136. Fujita M, Ishihara M, Simizu M, et al. Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-Anticoagulant heparin hydrogel. Biomaterials 2004;25:699-706
137. Sakiyama-Elbert SE, Hubbell JA. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. J Control Release 2000;69:149-58
138. Maynard HD, Hubbell JA. Discovery of a sulfated tetrapeptide that binds to vascular endothelial growth factor. Acta Biomater 2005;1:451-9
139. Cen L, Neoh KG, Li Y, Kang ET. Assessment of in vitro bioactivity of hyaluronic acid and sulfated hyaluronic acid functionalized electroactive polymer. Biomacromolecules 2004;5:2238-46
140. Chow LW, Bitton R, Webber MJ, et al. A bioactive self-Assembled membrane to promote angiogenesis. Biomaterials 2011;32:1574-82
141. Masters KS. Covalent growth factor immobilization strategies for tissue repair and regeneration. Macromol Biosci 2011;11:1149-63
142. Ehlert N, Hoffmann A, Luessenhop T, et al. Amino-modified silica surfaces efficiently immobilize bone morphogenetic protein 2 (BMP2) for medical purposes. Acta Biomater 2011;7:1772-9
143. Bentz H, Schroeder JA, Estridge TD. Improved local delivery of TGF-beta2 by binding to injectable fibrillar collagen via difunctional polyethylene glycol. J Biomed Mater Res 1998; 39:539-48
144. Wylie RG, Ahsan S, Aizawa Y, et al. Spatially controlled simultaneous patterning of multiple growth factors in three-dimensional hydrogels. Nat Mater 2011;10:799-806
145. Ehrbar M, Metters A, Zammaretti P, et al. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. J Control Release 2005;101:93-109
146. Stefonek TJ, Masters KS. Immobilized gradients of epidermal growth factor promote accelerated and directed keratinocyte migration. Wound Repair Regen 2007;15:847-55
147. Allazetta S, Cosson S, Lutolf MP. Programmable microfluidic patterning of protein gradients on hydrogels. Chem Commun (Camb) 2011; 47:191-3
148. Anitua E, Sanchez M, Orive G, Andia I. Delivering growth factors for therapeutics. Trends Pharmacol Sci 2008;29:37-41
149. Kohane DS. Microparticles and nanoparticles for drug delivery. Biotechnol Bioeng 2007; 96:203-9
150. Chakravarthi SS, De S, Miller DW, Robinson DH. Comparison of anti-tumor efficacy of paclitaxel delivered in nano- And microparticles. Int J Pharm 2010;383:37-44
151. Rockwood DN, Gil ES, Park SH, et al. Ingrowth of human mesenchymal stem cells into porous silk particle reinforced silk composite scaffolds: An in vitro study. Acta Biomater 2011;7:144-51
152. Ruhe PQ, Hedberg EL, Padron NT, et al. rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calciumphosphate cement composites. J Bone Joint Surg Am 2003;85-A(Suppl 3):75-81
153. Singh M, Morris CP, Ellis RJ, et al. Microsphere-based seamless scaffolds containing macroscopic gradients of encapsulated factors for tissue engineering. Tissue Eng Part C Methods 2008;14:299-309
154. Wischke C, Schwendeman SP. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm 2008;364:298-327
155. Akamatsu K, Chen W, Suzuki Y, et al. Preparation of monodisperse chitosan microcapsules with hollow structures using the SPG membrane emulsification technique. Langmuir 2010;26:14854-60
156. Liu XD, Yu WY, Zhang Y, et al. Characterization of structure and diffusion behaviour of Ca-Alginate beads prepared with external or internal calcium sources. J Microencapsul 2002;19:775-82
157. Jay SM, Shepherd BR, Andrejecsk JW, et al. Dual delivery of VEGF and MCP-1 to support endothelial cell transplantation for therapeutic vascularization. Biomaterials 2010;31:3054-62
158. Ferreira LS, Gerecht S, Fuller J, et al. Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials 2007;28:2706-17
159. Nkansah MK, Tzeng SY, Holdt AM, Lavik EB. Poly(lactic-co-glycolic acid) nanospheres and microspheres for short- And long-term delivery of bioactive ciliary neurotrophic factor. Biotechnol Bioeng 2008; 100:1010-19
160. Oliveira MB, Mano JF. Polymer-based microparticles in tissue engineering and regenerative medicine. Biotechnol Prog 2011
161. Zhang S, Uludag H. Nanoparticulate systems for growth factor delivery. Pharm Res 2009;26:1561-80
162. Xiang Q, Xiao J, Zhang H, et al. Preparation and characterisation of bFGF-encapsulated liposomes and evaluation of wound-healing activities in the rat. Burns 2011;27(4):897-912
163. Minear S, Leucht P, Jiang J, et al. Wnt proteins promote bone regeneration. Sci Transl Med 2010;2:29ra30
164. Tanaka SS, Kojima Y, Yamaguchi YL, et al. Impact of WNT signaling on tissue lineage differentiation in the early mouse embryo. Dev Growth Differ 2011;53:843-56
165. Popelut A, Rooker SM, Leucht P, et al. The acceleration of implant osseointegration by liposomal Wnt3a. Biomaterials 2010;31:9173-81
166. Cui W, Angsana J, Wen J, Chaikof EL. Liposomal formulations of thrombomodulin increase engraftment after intraportal islet transplantation. Cell Transplant 2010;19:1359-67
167. Chen JP, Chiang Y. Bioactive electrospun silver nanoparticles-containing polyurethane nanofibers as wound dressings. J Nanosci Nanotechnol 2010; 10:7560-4
168. Sahoo S, Toh SL, Goh JC. A bFGF-releasing silk/PLGA-based biohybrid scaffold for ligament/tendon tissue engineering using mesenchymal progenitor cells. Biomaterials 2010;31:2990-8
169. Patel S, Kurpinski K, Quigley R, et al. Bioactive nanofibers: Synergistic effects of nanotopography and chemical signaling on cell guidance. Nano Lett 2007;7:2122-8
170. McKeon-Fischer KD, Freeman JW. Characterization of electrospun poly(Llactide) and gold nanoparticle composite scaffolds for skeletal muscle tissue engineering. J Tissue Eng Regen Med 2010;5(7):560-8
171. Li C, Vepari C, Jin HJ, et al. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 2006;27:3115-24
172. Khan AS, Ahmed Z, Edirisinghe MJ, et al. Preparation and characterization of a novel bioactive restorative composite based on covalently coupled polyurethane-nanohydroxyapatite fibres. Acta Biomater 2008;4:1275-87
173. Cao H, Jiang X, Chai C, Chew SY. RNA interference by nanofiber-based siRNA delivery system. J Control Release 2010;144:203-12
174. Dong B, Smith ME, Wnek GE. Encapsulation of multiple biological compounds within a single electrospun fiber. Small 2009;5:1508-12
175. Ionescu LC, Lee GC, Sennett BJ, et al. An anisotropic nanofiber/microsphere composite with controlled release of biomolecules for fibrous tissue engineering. Biomaterials 2010;31:4113-20
176. Zeng J, Aigner A, Czubayko F, et al. Poly(vinyl alcohol) nanofibers by electrospinning as a protein delivery system and the retardation of enzyme release by additional polymer coatings. Biomacromolecules 2005;6:1484-8
177. Sill TJ, von Recum HA. Electrospinning: Applications in drug delivery and tissue engineering. Biomaterials 2008;29:1989-2006
178. Ehrbar M, Schoenmakers R, Christen EH, et al. Drug-sensing hydrogels for the inducible release of biopharmaceuticals. Nat Mater 2008;7:800-4
179. McCoy CP, Brady C, Cowley JF, et al. Triggered drug delivery from biomaterials. Expert Opin Drug Deliv 2010;7:605-16
180. Fisher OZ, Khademhosseini A, Langer R, Peppas NA. Bioinspired materials for controlling stem cell fate. Acc Chem Res 2010;43:419-28
181. Bawa P, Pillay V, Choonara YE, du Toit LC. Stimuli-responsive polymers and their applications in drug delivery. Biomed Mater 2009;4:022001
182. Tokarev I, Minko S. Stimuli-responsive porous hydrogels at interfaces for molecular filtration, separation, controlled release, and gating in capsules and membranes. Adv Mater 2010;22:3446-62
183. Lutolf MP, Lauer-Fields JL, Schmoekel HG, et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics. Proc Natl Acad Sci USA 2003;100:5413-18
184. Patterson J, Hubbell JA. Enhanced proteolytic degradation of molecularly engineered PEG hydrogels in response to MMP-1 and MMP-2. Biomaterials 2010;31:7836-45
185. Seliktar D, Zisch AH, Lutolf MP, et al. MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing. J Biomed Mater Res A 2004;68:704-16
186. Kraehenbuehl TP, Ferreira LS, Zammaretti P, et al. Cell-responsive hydrogel for encapsulation of vascular cells. Biomaterials 2009;30:4318-24
187. Kraehenbuehl TP, Zammaretti P, Van der Vlies AJ, et al. Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: Systematic modulation of a synthetic cell-responsive PEG-hydrogel. Biomaterials 2008;29:2757-66
188. Kim J, Kim IS, Cho TH, et al. In vivo evaluation of MMP sensitive high-molecular weight HA-based hydrogels for bone tissue engineering. J Biomed Mater Res A 2010;95:673-81
189. Chau Y, Luo Y, Cheung AC, et al. Incorporation of a matrix metalloproteinase-sensitive substrate into self-Assembling peptides - A model for biofunctional scaffolds. Biomaterials 2008;29:1713-19
190. Law B, Tung CH. Structural modification of protease inducible preprogrammed nanofiber precursor. Biomacromolecules 2008;9:421-5
191. Kloxin AM, Kasko AM, Salinas CN, Anseth KS. Photodegradable hydrogels for dynamic tuning of physical and chemical properties. Science 2009;324:59-63
192. Kloxin AM, Tibbitt MW, Kasko AM, et al. Tunable hydrogels for external manipulation of cellular microenvironments through controlled photodegradation. Adv Mater 2010;22:61-6
193. Kloxin AM, Benton JA, Anseth KS. In situ elasticity modulation with dynamic substrates to direct cell phenotype. Biomaterials 2010;31:1-8
194. Ehrick JD, Deo SK, Browning TW, et al. Genetically engineered protein in hydrogels tailors stimuli-responsive characteristics. Nat Mater 2005;4:298-302
195. Miyata T, Asami N, Uragami T. A reversibly antigen-responsive hydrogel. Nature 1999;399:766-9
196. Murakami Y, Maeda M. DNA-responsive hydrogels that can shrink or swell. Biomacromolecules 2005;6:2927-9
197. Monaghan M, Pandit A. RNA interference therapy via functionalized scaffolds. Adv Drug Deliv Rev 2011;63:197-208
198. Kohane DS, Langer R. Polymeric biomaterials in tissue engineering. Pediatr Res 2008;63:487-91
199. Kohane DS, Langer RS. Biocompatibility and Drug Delivery Systems. Chem. Sci 2010;1:441-46
200. Anderson DG, Levenberg S, Langer R. Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells. Nat Biotechnol 2004;22:863-6
201. Goldberg M, Langer R, Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed 2007;18:241-68
202. Dvir T, Timko BP, Brigham MD, et al. Nanowired three-dimensional cardiac patches. Nat Nanotechnol 2011;6:720-5
203. You JO, Rafat M, Ye GJ, Auguste DT. Nanoengineering the heart: Conductive scaffolds enhance connexin 43 expression. Nano Lett 2011;11:3643-8
204. Shmulewitz A, Langer R. The ascendance of combination products. Nat Biotechnol 2006;24:277-80
205. Timko BP, Cohen-Karni T, Qing Q, et al. Design and Implementation of Functional Nanoelectronic Interfaces With Biomolecules, Cells, and Tissue Using Nanowire Device Arrays. IEEE Trans Nanotechnol 2010;9:269-80
206. Santini JT Jr, Cima MJ, Langer R. A controlled-release microchip. Nature 1999;397:335-8